Thank you for joining us! Our Webinar will begin shortly.
|
|
- Erik Murphy
- 6 years ago
- Views:
Transcription
1 Introducing GlycoWorks RapiFluor-MS: Label N-Glycans Simply and Rapidly Without Sacrificing Sensitivity Thank you for joining us! Our Webinar will begin shortly. While you are waiting, please feel free to browse our library of Webinar content: Click below to learn more about CORTECS, our newest Solid-Core LC Column platform: Waters Corporation 1
2 Friendly Reminders Please use text chat functionality to submit questions during the Webinar. Upon conclusion, follow up information will be available: Recorded version of today s presentation PDF Copies of today s slides Discount Offers on GlycoWorks RapiFluor MS Products Product specific information Reference materials 2015 Waters Corporation 2
3 Today s Presenters Matthew Lauber, Ph.D - Senior Research Chemist, Waters Corporation Matthew Lauber is a Senior Applications Chemist in the Chemistry Applied Technology group. He has an academic background in protein chemistry and proteomic methods for the structural characterization of biomolecular complexes. Most recently Matt has worked extensively on chemistry products for bioseparations, with a specific focus on the new GlycoWorks RapiFluor MS kit we will discuss today. Paula Magnelli, Ph.D New England Biolabs Dr. Paula Magnelli is a Scientist at NEB Glycobiology Group. Paula is responsible for developing and characterizing novel glycosidases, creating methods for glycomics and glycoproteomics research with an emphasis in therapeutic glycoproteins workflows and glycan sequencing Waters Corporation 3
4 Introducing GlycoWorks RapiFluor-MS: Label N-Glycans Simply and Rapidly Without Sacrificing Sensitivity Matthew A. Lauber, Ph.D. Paula Magnelli, Ph.D Waters Corporation 4
5 Glycosylation of Biotherapeutics Fucose GlcNAc Mannose Effector Functions (ADCC/CDC) (fucosylation/galactosylation) Galactose N-acetylneuraminic acid N-glycolylneuraminic acid Low Half Life (high mannose) Anti-Inflammatory (sialylation) Immunogenic (αgal / N-glycolylneuraminic acid) Overall profile sensitive to manufacturing conditions N-glycosylation is a quality attribute of biotherapeutics N-glycan profiles are frequently characterized in detail and routinely monitored Anal Chem 2013, 85 (2), Waters Corporation 5
6 Glycoprotein Characterization Multiple Strategies Complementary Information 2015 Waters Corporation 6
7 Released Glycan Analysis HILIC Profiling Conventional 5 Hours to 2 Days Conventional 2+ 2-AB 5.3e2 FLR m/z 2015 Waters Corporation 7
8 Released Glycan Analysis Recent Developments Procainamide Klapoetke, S.; Zhang, J.; Becht, S.; Gu, X.; Ding, X., J Pharm Biomed Anal 2010, 53 (3), Rapid Rapid Tagging for MS Gong, B.; Hoyt, E.; Lynaugh, H.; Burnina, I.; Moore, R.; Thompson, A.; Li, H., Anal Bioanal Chem 2013, 405 (17), FLR Rapid Tagging for FLR Cook, K. S.; Bullock, K.; Sullivan, T., Biologicals 2012, 40 (2), MS 2015 Waters Corporation 8
9 Part I Development of the GlycoWorks RapiFluor-MS N-Glycan Kit 2015 Waters Corporation 9
10 Glycan Labeling Techniques Rapid Tagging N-Glycan PNGase F Protein Reductive Amination (conventional) Glycosylamine labeling with rapid tagging reactive groups circumvents these issues Released N-Glycan (Glycosylamine) N-Glycan (Glycosylamine) + Mild Acid Hydrolysis Protein Relies on numerous chemical conversions Laborious Time consuming Often produces heterogenous reaction products N-Glycan ( Acyclic Free Reducing End) + N-Glycan (Free Reducing End) HOAc DMSO 2-AB SPE NaBH 3 CN Reduction N-Glycan (2-AB Labeled) 2015 Waters Corporation 10
11 RapiFluor-MS TM Reagent Built Upon Our Expertise From Waters expertise in rapid, fluorescence labeling of amino acids Enhanced chemical properties for glycan analysis: Rapid Tagging Efficient Fluorescence Enhanced Ionization Efficiency RapiFluor-MS AccQ Fluor Rapid Fluorescence Patent Pending Exclusive Licensing 2015 Waters Corporation 11
12 RapiFluor-MS Reagent Rapid Labeling Kinetics Mechanism for Rapid Tagging of Glycosylamines with RapiFluor-MS NHS Carbamate Rapid Tagging Group rapifluor-ms Tertiary Amine MS-Active Charge Tag + mass (glycosylamine) Glycosylamine = Da (reducing end) = Da +C 17 H 20 N 4 O 2 time = Quinoline Fluorophore Monoisotopic mass shift (from glycosylamine) secondsda H 2 O CO Waters Corporation 12
13 Revolutionizing N-Glycan Sample Prep Sensitivity Comparison Instant AB TM 2.6E+6 RapiFluor-MS Labeled N-Glycans FA2 FLR 400 FLR MS (BPI) 0.0E+0 1.7E+6 2.6E+6 0.0E+0 1.7E+6 FA2 FA2 300x zoom MS (BPI) 0.0E min Instant AB Labeled N-Glycans FA2 FLR MS (BPI) actors ple of N-Glycans ss Check Std/ 1000) Response Fa (FA2 Peak Area per Samp from 1 µg of Intact mab Mas RapiFluor-MS Labeled Instant AB Labeled 0.0E min 2015 Waters Corporation 13
14 Revolutionizing N-Glycan Sample Prep Quantitative Analysis to Compare to Convention Rapid Tagging RapiFluor-MS rapifluor-ms Different Mechanisms Reductive Amination 2-AB H O 3.3E+6 FLR 0.0E+0 4.0E+6 MS (BPI) 0.0E+0 FA2 (2.2 pmol) (Area = x 10 3 ) RapiFluor-MS Labeled Human IgG N-Glycans FA2 (Area = x 10 3 ) higg FA2 Peak Area (Fluorescence - Ex 265 nm / Em 425 nm) y = x Quantity (pmol) E+6 8E+5 6E+5 4E+5 2E+5 0E+0 y = x R² = RapiFluor-MS Label (pmol) 2015 Waters Corporation 14
15 Revolutionizing N-Glycan Sample Prep Quantitative Analysis to Compare to Convention Rapid Tagging RapiFluor-MS rapifluor-ms Different Mechanisms Reductive Amination 2-AB H O 3.0E+5 FLR 0.0E+0 3.0E+4 MS (BPI) 0.0E+0 FA2 (2.6 pmol) (Area = 19.3 x 10 3 ) 2-AB Labeled Human IgG N-Glycans FA2 (Area = 2.0 x 10 3 ) higg FA2 Peak Area (Fluorescence - Ex 330 nm / Em 420 nm) y = x Quantity (pmol) E+4 6E+4 5E+4 4E+4 3E+4 2E+4 1E+4 0E+0 y = x R² = AB Label (pmol) 2015 Waters Corporation 15
16 Revolutionizing N-Glycan Sample Prep Sensitivity Comparison 2-AB 3.3E+6 0.0E+0 4.0E+6 0.0E+0 3.3E+6 0.0E+0 4.0E+6 0.0E+0 RapiFluor-MS Labeled N-Glycans from Pooled Human IgG FA2 (2.2 pmol) FA2 FLR MS (BPI) AB Labeled N-Glycans from Pooled Human IgG FA2 (2.6 pmol) 100x zoom FLR actors d FA2 Glycan / 1000) FA2 7.4 MS (BPI) Response Fa (Peak Area per pmol of Labeled RapiFluor-MS Labeled FLR MS (BPI) AB Labeled 2015 Waters Corporation 16
17 Revolutionizing N-Glycan Sample Prep Sensitivity Comparison Fluorescence MS (BPI) RapiFluor-MS Labeled Instant AB Labeled 2-AB Labeled Procainamide Labeled Relative Per rformance (%) * * (*) Comparative result extrapolated from a published comparison of N-glycans, wherein it was found that procainamide provided comparable fluorescence and up to 50 fold greater ESI-MS sensitivity when compared to 2-AB(Klapoetke et al. 2010) Waters Corporation 17
18 Simplified Workflow Conventional 5 Hours to 2 Days Direct Analysis (Organic Solvent Dilution) 10 min 5 min 10 min GlycoWorks RapiFluor-MS N-Glycan Kit Total Sample Prep Time 30 min Patent Pending 2015 Waters Corporation 18
19 Powered by New England Biolabs :: Global leader in the production and supply of reagents for the life sciences :: Innovator of technologies from basic molecular biology through to next generation sequencing and high throughput genomics :: Provider of best-in-class products with unparalleled technical support :: Manufacturer of reagents for glycan analysis for over 20 years 1974 NEB founded 1992 Maltose Binding Protein Expression Kit Released 1994 Chitin research begins 2007 K. lactis glycoengineered strains 2011 Heparinases released 2014 Rapid PNGase F released Dwek coins term glycobiology 1992 PNGase F, Endo H & first exos released 1990 NEB glycobiology program formed 2000 α-n-acetyl- Galactosaminidase released 2005 Cellulase research begins 2008 Novel O-glycosidase released 2012 Endo S released 2014 Human GPI glycoproteome published 2015 Waters Corporation 19
20 Rapid Deglycosylation RapiGest SF and Glycoworks Rapid PNGase F RapiGest SF Surfactant GlycoWorks Rapid Buffer GlycoWorks Rapid PNGase F Enzymatic Deglycosylation 2 min 80 C 5 min 50 C 2015 Waters Corporation 20
21 Revolutionizing N-Glycan Sample Prep Rapid Deglycosylation (-) Negative Control (no enzyme) (+) Positive Control (SDS/DTT + PNGase F) (R) Rapid Deglycosylation (RapiGest, Rapid PNGase F, 10 min). Positive control: denaturation with DTT-SDS (incompatible with MS applications), followed by PNGase F treatment is a well established method for complete N-glycan removal. Rapid deglycosylation: complete unbiased N-glycan removal in 10 minutes, compatible with rapid labeling and mass spectrometry analysis Waters Corporation 21
22 Revolutionizing N-Glycan Sample Prep Speed: Fast Deglycosylation (-) Negative Control (no enzyme) (R) Rapid Deglycosylation (RapiGest, Rapid PNGase F, 10 min) (RT) Rapid Deglycosylation with 4mM TCEP (+) Positive Control (SDS/DTT + PNGase F) 2015 Waters Corporation 22
23 Revolutionizing N-Glycan Sample Prep Speed: Fast Deglycosylation Glycoprotein + Rapid Buffer + Rapigest SF + Rapid PNGase F 2 min 80 C 5 min 50 C 2015 Waters Corporation 23
24 Revolutionizing N-Glycan Sample Prep Robustness: Quantitative Extraction Labeled Glycan Reaction Byproducts Labeled Deglycosylated Protein Collect Byproducts Labeled Glycan 2015 Waters Corporation 24
25 Revolutionizing N-Glycan Sample Prep Robustness: Quantitative Extraction Mixture of higg and bovine fetuin N-glycans 2.3E+6 FLR No SPE Crude Reaction Mixture A3G3S3 FA2 FA2G2S1 A3S1G3S3 RapiFluor-MS FA2 Fluorescence Peak Area 0.0E+0 6E+8 1.9E+6 After SPE (1x SPE) SPE Recovery 5E+8 ~74% 4E+8 3E+8 2E+8 Specified elution volume 0.0E E+8 0E SPE Elution Volume (µl) 2015 Waters Corporation 25
26 Revolutionizing N-Glycan Sample Prep Robustness: Quantitative Extraction 1.2E+6 1x SPE A3G3S3 30 FLR 25 1x SPE Positive Control FA2 A3S1G3S3 FA2G2S1 0.0E E+6 2x SPE Relative Ab bundance (%) x SPE SPE Processed Positive Control 5 5.7% 6.1% 0 0.0E+0 min GlycoWorks HILIC SPE of RapiFluor-MS N-Glycans is quantitative No significant deviation in the glycan profile upon SPE processing 2015 Waters Corporation 26
27 Revolutionizing N-Glycan Sample Prep Robustness: Optimized Labeling Labeling optimized for high yield and minimization of artifacts Glycoprotein Concentration 0.36 mg/ml RapiFluor-MS Concentration 18 mm 36 mm 54 mm 72 mm 108 mm 1.6E+5 FA2 G0F Fluorescence Peak Area Maximized yield 4 9 min 0.0E RapiFluor-MS Reagent Concentration (mm) Patent Pending 2015 Waters Corporation 27
28 Revolutionizing N-Glycan Sample Prep Robustness: Optimized Labeling Labeling optimized for high yield and minimization of artifacts Not Optimized High Ionic Strength ph mm Reagent Overlabeled BPI FA2 +2 Labels 10x zoom FA2G1 ~1% +2 Labels 0.3 Optimized 50 mm HEPES ph mm Reagent Overlabeled 0.1% BPI A2 10x zoom (FA2 +1 Label / FA2 +2 Labels) % Overlabeled Minimization of artifacts + Maximized yield RapiFluor-MS Reagent Concentration (mm) Patent Pending 2015 Waters Corporation 28
29 Revolutionizing N-Glycan Sample Prep Robustness: High Yield N-Glycan Yield (entire workflow) ~73% 2E+6 0E+0 FA2 Rep #1 1.6 pmol Rep #2 1.7 pmol 100% Theoretical Yield = 2.3 pmol 1.5x pmol 2 pmol glycan 0.45 pmol FA2 10 µl injection pg IgG X X X X 150,000 pg 1 pmol IgG 1 pmol total 400 µl = 2.3 pmol glycan pool sample prepared Peak Area (Fluorescence - Ex 265 nm / Em 425 nm) 1E+6 8E+5 6E+5 4E+5 2E+5 0E+0 y = x R² = RapiFluor-MS Label (pmol) 2015 Waters Corporation 29
30 Revolutionizing N-Glycan Sample Prep Robustness: High Yield with Minimal Bias Step Yield Testing to Confirm Minimal Bias Deglycosylation FA2 Rep #1 1.6 pmol Rep #2 1.7 pmol Complete Labeling >95% SPE ~74% GlycoWorks RapiFluor-MS N-Glycan Kit GlykoPrep Rapid N-Glycan Preparation with 2-AB 100% Theoretical Yield = 2.3 pmol Intact mass analysis / Subunit LC-MS Gel shift assays Released glycan profile vs subunit derived glycan information Recovery measurements Glycan profile before vs after SPE ~73% Yield ~35% Yield GlykoPrep is a copyright of Prozyme. These values may not be representative of all applications Waters Corporation 30
31 Revolutionizing N-Glycan Sample Prep Robustness: Stable Glycan Derivatives Fluorescence 10x zoom Intial 0 Hours 3 Days 72 Hours Initial min 10x zoom Fluorescen nce Peak Areas After 3 days 10 C min No significant change in the glycan FLR signal even after 3 days at 10 C Stable glycan derivatives 0 A2 FA2 FA2G1 FA2G1(iso) FA2G2 FA2G2Sg1 FA2G2Ga Waters Corporation 31
32 Summary Part I Preparation of labeled N-glycans (from glycoprotein to analysis ready sample) in 30 minutes Unprecedented sensitivity for labeled N- glycans Complete deglycosylation producing unbiased results Simple, streamlined protocol Accurate profiling based on robust SPE for neutral to tetrasialylated N-glycans RapiFluor-MS GlycoWorks RapiFluor-MS N-Glycan Kit 2015 Waters Corporation 32
33 Part II GlycoWorks RapiFluor-MS N-Glycan Work 2015 Waters Corporation 33
34 Glycan Characterization Using UPLC/FLR/Xevo G2-XS QTof Conventional 2-AB Glycan from 10 µg of Protein 1.5 Day Sample Prep 1: TOF MS ES+ BPI 6.93e6 RapiFluor-MS Glycan from 0.1 µg Protein <1 hr Sample Prep 100x Sensitivity Characterization min High Resolution LC-MS(/MS) Example courtesy of Y. Yu 2015 Waters Corporation 34
35 Glycan Characterization Using UPLC/FLR/Xevo G2-XS Conventional 2-AB Glycan from 10 µg of Protein 1.5 Day Sample Prep , 2+ FA2G2Ga1 RapiFluor-MS Glycan from 0.1 µg Protein <1 hr Sample Prep 100x Sensitivity min 1: TOF MS ES+ BPI 6.93e m/z Characterization High Resolution LC-MS(/MS) Example courtesy of Y. Yu 2015 Waters Corporation 35
36 Glycan Characterization Enhanced Electrospray Ionization RapiFluor-MS 2-AB FA e6 2.9e m/z m/z FA2BG2S e5 1.15e e m/z m/z 2015 Waters Corporation 36
37 Glycan Characterization Information-Rich MS/MS Spectra QTof Collision Induced Dissociation FA2 Contiguous series of glycosydic bond fragments (Near exclusively containing label) MS/MS spectra additionally contain some cross ring fragmentation 2015 Waters Corporation 37
38 Glycan Characterization Detailing the N-Glycan Profile of a mab 2.1E+6 FLR Intact mab Mass Check Standard anti-citrinin murine monoclonal IgG1 0.0E+6 8.4E+6 MS Rapid Preparation Deglycosylation Labeling SPE 30 min 0.0E Waters Corporation 38
39 Glycan Characterization Detailing the N-Glycan Profile of a mab FLR Intact mab Mass Check Standard anti-citrinin murine monoclonal IgG1 MS Peak No. Glycan Name Obs Mass Mass Error Approximate (M+H) + (ppm) Relative% F: Fucose A: Antennary G: Galactose B: Bisecting Ga: Alpha-galactose Sg: N-glycolylneuraminic acid iso: Structural isomer 1 A FA A FA A2G FA1G < A2G1(iso) FA2G FA2G1(iso) FA2G1B FA2G1B (iso) FA2G FA2G1Ga FA2G2Ga FA2G2Sg FA2G2Sg1(iso) FA2G2Ga FA2G2GaSg FA2G2Ga1Sg1(iso) Waters Corporation 39
40 Glycan Characterization Detailing the N-Glycan Profile of a mab FLR Intact mab Mass Check Standard anti-citrinin murine monoclonal IgG1 MS FA2G2? Zoom 10x 2015 Waters Corporation 40
41 Glycan Characterization Detailing the N-Glycan Profile of a mab Relative Abundance 8.0% Relative Abundance 0.7% Prominent 528 m/z ion and loss of GlcNAc 2015 Waters Corporation 41
42 Glycan Characterization Detailing the N-Glycan Profile of a mab FLR Intact mab Mass Check Standard anti-citrinin murine monoclonal IgG1 MS FA2G2? FA2G1Ga1 Zoom 10x 2015 Waters Corporation 42
43 Glycan Monitoring Transferability UPLC / HPLC H-Class BIO UPLC ACQUITY UPLC Glycan BEH Amide, 130Å, 1.7µm 2.1 X 150 mm Flow Rate: 0.40 ml/minute Fluorescence (relative) Total Run Time = 55 minutes Alliance HPLC XBridge Glycan BEH Amide, 130Å, 2.5µm 3.0 X 225 mm total length (150 mm + 75 mm) Flow Rate: 0.56 ml/minute Total Run Time = minutes Time (minutes) Comparable sensitivity and resolution 3x sample load / 2x increase in time Transfer between labs with different LC equipment capabilities 2015 Waters Corporation 43
44 Glycan Monitoring UPLC/FLR/ACQUITY QDa Mass Detector FLR Rountine Analysis with Mass Detection Detection across a broad range of glycan species: IgG Simple bi-antennery structures RNase B High mannose structures QDa Fetuin Large, complex structures 3x 3x Monitoring Minutes Intermediate Technology UPLC-FLR UPLC-Mass Detection Example courtesy of S. McCarthy 2015 Waters Corporation 44
45 Glycan Monitoring UPLC/FLR/ACQUITY QDa Mass Detector FLR QDa 2015 Waters Corporation 45
46 GlycoWorks RapiFluor-MS Standards RapiFluor-MS Glycan Performance Test Standard FLR Labeled Glycans of IgG Pooled from Human Serum 400 pmol FA FA2BG2S2 Peak Glycan Approx RT (min) Approx Rel Abund (%) 1 A FA FA2B A2G A2G FA2G FA2G FA2BG FA2BG A2G FA2G FA2BG FA2G1S FA2G2S FA2BG2S FA2G2S FA2BG2S MS (BPI) System suitability Method familiarization Benchmarking Troubleshooting Waters Corporation 46
47 LC Calibration with Labeled Dextran 10 Calibration Curve EU n GU Value Log Mol Wt Cubic Spline Fitting Retention Time (min) Retention Time (min) Retention Time (min) 2015 Waters Corporation 47
48 LC Calibration with Labeled Dextran 10 Calibration Curve min GU Value g Mol Wt Log Cubic Spline Fitting EU Retention Time (min) Retention Time (min) GU 5.85 GU 5.95 GU Retention Time (min) 2015 Waters Corporation 48
49 LC Calibration with Labeled Dextran 35 Multiple sites reporting on one glycan profile Cubic Spline Fit Type Retentio on Time (min) Significant deviations in RTs GU Value RSD max = 8.50 RSD max = Glycan Profile Component Glycan Profile Component GU values improve the robustness of data reporting 2015 Waters Corporation 49
50 LC Calibration with Labeled Dextran Dextran no amine to modified with rapid tagging reagents Reductive amination with analogs is disadvantageous - different physicochemical properties due to different linkage - FLR wavelengths / basicity / pkas / polarity / HILIC retention RapiFluor-MS Labeled N-Glycans Reductive Amination With an Analog Novel Dextran Ladder Dextran Glycan Dextran x λ Excitation,Max =265 nm 235 nm 240 nm Ex 265 nm 245 Em 425 nm λ Emission,Max =425 nm 250 nm 255 nm 260 nm 265 nm Ex 370 nm Em 480 nm 325 nm 370 nm x x Ex 265 nm 265 nm Em 425 nm 315 nm 265 nm 270 nm 275 nm 365 nm 280 nm 285 nm 290 nm 295 nm nm nm nm 2015 Waters Corporation 50
51 GlycoWorks RapiFluor-MS Standards RapiFluor-MS Dextran Calibration Ladder 50 µg of a Novel Dextran Ladder FLR properties match RapiFluor-MS labeled glycans Tuned for HILIC Retention Dextran RapiFluor-MS Label Ethanolamino Urea Linkage FLR GU 3 MS (BPI) min Patent Pending 2015 Waters Corporation 51
52 GlycoWorks Mobile Phase Concentrate High purity mobile phases are critical to successful glycan LC-MS LC-MS Grade LC-MS grade mobile phase concentrate Eliminate concerns on NH 4 HCOOH purity and glass-ware cleanliness 10 ml concentrate simply poured into a 1L bottle of LC-MS water Not LC-MS Grade Adduct Formation Na K KCl / NaCl 2015 Waters Corporation 52
53 Summary Part II N-glycan characterization facilitated by combining RapiFluor-MS labeling and high sensitivity QTof MS RapiFluor-MS enhances ESI of glycans, producing high charge state, protonated ions RapiFluor-MS enables the possibility of QDa mass detection during routine analyses In addition to the GlycoWorks RapiFluor- MS N-glycan kit, new glycan standards and reagents have been developed to support analytical workflows, such as GU value assignment RapiFluor-MS GlycoWorks RapiFluor-MS N-Glycan Kit Calibration Ladder Dextran RapiFluor-MS Label Ethanolamino Urea Linkage 2015 Waters Corporation 53
54 Useful Literature Application Notes / Publications Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Novel Fluorescence and MS-Active Labeling Reagent Waters Application Note EN. January Robustness of RapiFluor-MS N-Glycan Sample Preparation and HILIC Analysis Waters Application Note in preparation. March Manuscript in preparation Posters WCBP 2015 / P-206-W Routine Monitoring of N-Glycans Using a Novel Labeling Reagent with Fluorescence and Mass Detection WCBP 2015 / P-216-W Rapid Preparation of N-Glycans Using a Novel Fluorescence and MS Active Labeling Reagent WCBP 2015 / P-115-T Developing a Scientific Library for UPLC/FLR/MS Analysis of Released N-glycans Labeled with a Novel Waters Corporation 54
55 Thank You for Attending! Post-Event Home Page: 30% Introductory Offer On GlycoWorks RapiFluor-MS Full Webinar Recording of Today s Session w/pdf Slide Deck Compilation of TODAY S KEY Literature, Brochures etc For Questions and to Submit your Ideas for our Next Topic Please - mychemrep@waters.com 2015 Waters Corporation 55
Eoin F.J. Cosgrave, Matthew A. Lauber, Robert Birdsall, and Sean M. McCarthy Waters Corporation, Milford, MA, USA APPLICATION BENEFITS INTRODUCTION
New Capabilities for Monitoring Released N-Glycans through the Combined Use of RapiFluor-MS Labeling, ACQUITY UPLC H-Class Bio System, and Serial Fluorescence/ACQUITY QDa Mass Detection Eoin F.J. Cosgrave,
More informationDedicated UPLC Chemistries for BioTherapeutics Joe Walsh WITS BioPharm Session 2016
Dedicated UPLC Chemistries for BioTherapeutics Joe Walsh WITS BioPharm Session 2016 2016 Waters Corporation 1 Market Drivers In 2014, 5/10 of the top selling drugs globally were monoclonal antibodies (mabs)
More informationThe Ludger GX-mAb Glycoprofiling Service High Throughput glycan analysis service of monoclonal antibodies (mabs) for drug developers and manufacturers
The Ludger GX-mAb Glycoprofiling Service High Throughput glycan analysis service of monoclonal antibodies (mabs) for drug developers and manufacturers Dr Richard Gardner Senior Chemist richard.gardner@ludger.com
More informationTrastuzumab Glycan Batch-to-Batch Profiling using a UPLC/FLR/Mass Spectrometry Platform
Trastuzumab Glycan Batch-to-Batch Profiling using a UPLC/FLR/Mass Spectrometry Platform Ying Qing Yu, Joomi Ahn, and Martin Gilar Waters Corporation, Milford, MA, U.S. APPLICATION BENEFITS Used together,
More informationGlycoWorks RapiFluor-MS N-Glycan Kit
CTETS I. ITRDUCTI II. STRAGE AD STABILITY III. USIG THE GLYCWRKS RAPI FLUR-MS -GLYCA KIT IV. RDERIG IFRMATI V. REFERECES this kit contains a novel rapid label called RapiFluor-MS, a reagent purposefully
More informationAnalysis of Monoclonal Antibody N-glycans by Fluorescence Detection and Robust Mass Selective Detection Using the Agilent LC/MSD XT
Analysis of Monoclonal Antibody N-glycans by Fluorescence Detection and Robust Mass Selective Detection Using the Agilent LC/MSD XT Application Note Biotherapeutics & Biologics Authors Oscar Potter, Gregory
More informationN-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF
N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF Application Note Authors Xianming Liu, Wei Zhang, Yi Du, Sheng Yin, Hong Que, and Weichang Zhou WuXi AppTec iopharmaceuticals
More informationADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS
ADVANCING ATTRIBUTE CONTROL OF ANTIBODIES AND ITS DERIVATIVES USING HIGH RESOLUTION ANALYTICS Henry Shion 1, Jing Fang 1, William Alley 1, Barbara Sullivan 2, Nick Tomczyk 3, Liuxi Chen 1, Ying-Qing Yu
More informationmab Glycopeptide Profiling with V-Tag Adding reliable glycoprofiling to your peptide mapping workflow with ease and simplicity
mab Glycopeptide Profiling with V-Tag Adding reliable glycoprofiling to your peptide mapping workflow with ease and simplicity Who is the V-Tag Glycoprofiling Technology for? V = Velocity The Ludger V-Tag
More informationProfiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 6545XT AdvanceBio LC/Q TOF
Application Note Biotherapeutics and Biosimilars Profiling Glycosylation of Monoclonal Antibodies at Three Levels Using the Agilent 64XT AdvanceBio LC/Q TOF Author David L. Wong Agilent Technologies, Inc.
More informationAccelerate mab Characterization Using Automated Sample Prep
Accelerate mab Characterization Using Automated Sample Prep David Knorr, Ph.D. Automation Solutions Ning Tang, Ph.D. LC/MS 15 February 2012 Page 1 Protein Sample Processing Workflows Glycan Profiling Biological
More informationBiotherapeutic Non-Reduced Peptide Mapping
Biotherapeutic Non-Reduced Peptide Mapping Routine non-reduced peptide mapping of biotherapeutics on the X500B QTOF System Method details for the routine non-reduced peptide mapping of a biotherapeutic
More informationA Comprehensive Approach for Monoclonal Antibody N-linked Glycan Analysis from Sample Preparation to Data Analysis
Application ote Biotherapeutics and Biosimilars A Comprehensive Approach for Monoclonal Antibody -linked Glycan Analysis from Sample Preparation to Data Analysis Authors David L. Wong, scar Potter, Jordy
More informationSeparation of Native Monoclonal Antibodies and Identification of Charge Variants:
Separation of Native Monoclonal Antibodies and Identification of Charge Variants: Teamwork of the Agilent 31 OFFGEL Fractionator, Agilent 21 Bioanalyzer and Agilent LC/MS Systems Application Note Biosimilar
More information2012 Waters Corporation 1
UPLC User meeeting April 2012 Principles and Practices for SEC, IEX for Intact Protein Analysis by UPLC anders_feldthus@waters.com 2012 Waters Corporation 1 Agenda Ion-Exchange Chromatography Theory and
More informationDeveloping Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus
Developing Robust and Efficient IEX Methods for Charge Variant Analysis of Biotherapeutics Using ACQUITY UPLC H-Class System and Auto Blend Plus Robert Birdsall, Thomas Wheat, and Weibin Chen Waters Corporation,
More informationRapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies
CE Pharm 2014, Seattle, WA, Oct 13-16, 2014 Rapid magnetic bead based sample preparation for automated and high throughput N-glycan analysis of therapeutic antibodies Csaba Váradi 1, Clarence Lew 2 and
More informationRepeatability of C100ht Biologics Analyzer, for High Throughput Glycan Screening
Repeatability of C100ht Biologics Analyzer, for High Throughput Glycan Screening Marcia Santos, Tingting Li, Mervin Gutierrez, Anna Lou, and Clarence Lew SCIEX Separations, Brea, CA Introduction The ability
More informationCharged Surface Hybrid C18 for High Resolution LC and LC/MS Peptide Separations
Charged Surface Hybrid C18 for High Resolution LC and LC/MS Peptide Separations Higher Quality Peptide Separations Using Hybrid Particle-Based Reversed-Phase Columns and CSH Technology 2013 Waters Corporation
More informationProteins. Patrick Boyce Biopharmaceutical Marketing Manager Waters Corporation 1
Routine Characterization of mabs and Other Proteins Patrick Boyce Biopharmaceutical Marketing Manager Europe and India 2011 Waters Corporation 1 Agenda Why? What scientific challenges? Technology Example
More informationLC/MS Based Quantitation of Intact Proteins for Bioanalytical Applications
LC/MS Based Quantitation of Intact Proteins for Bioanalytical Applications Alex Zhu, Ph.D. Agilent Technologies Wilmington, DE ASMS,2017-06 1 Outline Introduction on intact protein quantitation Agilent
More informationBackground - Importance of monoclonal antibody characterization
mab-glyco Chip Kit Zuckerhuetl PP/PR Checkpoint December 14, 2010 1 Background - Importance of monoclonal antibody characterization Monoclonal antibodies (mabs) are glyco- proteins bearing complex oligosaccharide
More informationDeveloping Quantitative UPLC Assays with UV
Developing Quantitative UPLC Assays with UV Detection for Antibodies & Other Proteins Steve Taylor 2011 Waters Corporation 1 Outline UPLC technology for RP protein separations Method development parameters
More informationSean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL RESULTS AND DISCUSSION
UPLC Separation of DNA Duplexes Sean M. McCarthy and Martin Gilar Waters Corporation, Milford, MA, U.S. INTRODUCTION Over the past 2 years there has been a considerable amount of effort focused on the
More informationAdvanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D.
Advanced Characterization of Antibody Drug Conjugates (ADCs) by Liquid Chromatography and Mass Spectrometry (LC/MS) John Gebler, Ph.D. Director www.waters.com/adc 2015 Waters Corporation 1 2015 Waters
More informationIsotopic Resolution of Chromatographically Separated IdeS Subunits Using the X500B QTOF System
Isotopic Resolution of Chromatographically Separated IdeS Subunits Using the X500B QTOF System Fan Zhang 2, Sean McCarthy 1 1 SCIEX, MA, USA, 2 SCIEX, CA USA Analysis of protein subunits using high resolution
More informationAnswers, Simple and Streamlined. Solutions for Biotherapeutic Intact Mass Analysis
Answers, Simple and Streamlined Solutions for Biotherapeutic Intact Mass Analysis Expert Functionality for Mass Spec Non-Experts SCIEX OS on the X500B QTOF system dramatically improves the user experience,
More informationMaximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns
Maximizing Chromatographic Resolution of Peptide Maps using UPLC with Tandem Columns Hongwei Xie, Martin Gilar, and Jeff Mazzeo Waters Corporation, Milford, MA U.S. APPLICATION BENEFITS The ACQUITY UPLC
More informationApplication Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins
Application Note # ET-20 BioPharma Compass: A fully Automated Solution for Characterization and QC of Intact and Digested Proteins BioPharma Compass TM is a fully automated solution for the rapid characterization
More informationBiochromatography Bring more Zen into your life and laboratory
Seminar Biochromatography Bring more Zen into your life and laboratory Method development and maintaining peptide, protein, glycan and anti-body analyses by LC or LC-MS can be very time consuming and might
More informationValidation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic
Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic By J. Tompkins1, T. Spurgeon 1, R. Tobias 1, J. Anders1,
More informationFOR RESEARCH USE ONLY STORE AT -20 C
FOR RESEARCH USE ONLY www.genovis.com STORE AT -20 C INSTRUCTIONS FOR PRODUCTS IgGZERO 1000 units (A0-IZ1-010) Deglycosylation of up to 1 mg IgG IgGZERO 5000 units (A0-IZ1-050) Deglycosylation of up to
More informationAnalytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars
Analytical Characterization of Biotherapeutics: Looking to the Future with Biosimilars Jared Auclair, Ph.D. Northeastern University Department of Chemistry and Chemical Biology Barnett Institute of Chemical
More informationRediscover the Strengths of Your PA 800 Plus - A Multi-Attribute Protein Analyzer
Rediscover the Strengths of Your PA 800 Plus - A Multi-Attribute Protein Analyzer Marcia R Santos SCIEX Separations, Brea, CA Introduction Capillary Electrophoresis is a well-accepted analytical separation
More informationAutomating the C100ht Biologics Analyzer Sample Preparation on a Biomek i5 Liquid Handler Platform
Automating the C100ht Biologics Analyzer Sample Preparation on a Biomek i5 Liquid Handler Platform Mervin Gutierrez, Tingting Li, and Marcia Santos SCIEX Separations, Brea, CA Introduction There is an
More informationUnified Workflow for Monoclonal Antibody Charge Heterogeneity, Purity, and Molecular Weight Analysis
Procedures Unified Workflow for Monoclonal Antibody Charge Heterogeneity, Purity, and Molecular Weight Analysis Separation and Online Detection of Intact mab Variants and Impurities using CESI-MS Bryan
More informationChromatography column for therapeutic protein analysis
PRODUCT SPECIFICATIONS ProPac Elite WCX Column Chromatography column for therapeutic protein analysis Benefits Superior resolution power for proteins, monoclonal antibodies, and associated charge variants
More informationBiotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method
Biotherapeutic Peptide Mapping Information Dependent Acquisition (IDA) Method Routine biotherapeutic accurate mass peptide mapping analysis on the X500B QTOF System Method details for the routine peptide
More informationAsish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation, Milford, MA, U.S. INTRODUCTION METHODS. Sample preparation
Com p r e h ensiv e a n d Rou t in e C ha r ac t e riz at io n o f P rot eins a n d P e p t i d e s by LC/MS and LC/MS E Asish Chakraborty, St John Skilton, Weibin Chen and John C. Gebler Waters Corporation,
More informationWorkflows for the Characterization of Glycan structure on Biotherapeutics
New Innovations in UHPLC and LC-MS Workflows for the Characterization of Glycan structure on Biotherapeutics Ken Cook EU Bio-Separations Support Expert April 2015 1 The world leader in serving science
More informationAPPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEY WORDS
Using Hydrophilic Interaction Chromatography for Heightened Product Characterization to Overcome Challenges with Hydrophobic Monoclonal Antibodies and Antibody Drug Conjugates Jacquelynn Smith, 1 Matthew
More informationHigh-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography
High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography Agilent 1260 Infinity Bio-inert Quaternary LC System with Agilent Bio Columns
More informationOverview of Waters Solutions for Biopharmaceutical Analysis and Characterization
Overview of Waters Solutions for Biopharmaceutical Analysis and Characterization Denis Calnan Biopharma Business Development Manager (Northern Europe) 2011 Waters Corporation 1 About Waters Facts and Figures
More informationAnalysis of Intact Monoclonal Antibodies Using an M3 MicroLC with the TripleTOF 6600
Procedures Analysis of Intact Monoclonal Antibodies Using an M3 MicroLC with the TripleTOF 66 Robust and Sensitive Workflow for Qualitative and Quantitative Analysis of Biotherapeutic IgGs Khatereh Motamedchaboki,
More informationAnalysis of biomolecules by SEC and Ion-Exchange UPLC
Analysis of biomolecules by SEC and Ion-Exchange UPLC Anders Feldthus, Waters Nordic 2011 Waters Corporation 1 Waters Commitment To develop, commercialize and market columns that when used on Waters ACQUITY
More informationProduct Guide for LudgerSep TM N2 High Resolution Amide HPLC Columns for Glycan Analysis
Product Guide for LudgerSep TM N2 High Resolution Amide HPLC Columns for Glycan Analysis (Ludger Product Codes: LS-N2-4.6x150 and LS-N2-2.0x150) Ludger Document # LS-N2-Guide-v4.0 Ludger Ltd Culham Science
More informationQuantification of Host Cell Protein Impurities Using the Agilent 1290 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System
Application Note Biotherapeutics Quantification of Host Cell Protein Impurities Using the Agilent 9 Infinity II LC Coupled with the 6495B Triple Quadrupole LC/MS System Authors Linfeng Wu and Yanan Yang
More informationBiomolecule Purification, Characterization, and Analyses
Biomolecule Purification, Characterization, and Analyses Biomolecule Purification, Characterization, and Analyses Quality is always about having a consistent product. ~ Aoife Hayes, Technical Service Manager,
More informationMassPREP On-Line Desalting Cartridge
CONTENTS I. INTRODUCTION II. INSTALLING THE MASSPREP ON-LINE DESALTING CARTRIDGE INTO THE SENTRY.1 X 1 MM GUARD COLUMN HOLDER III. RECOMMENDED LC/MS SYSTEM CONFIGURATION TO MINIMIZE MS SOURCE CONTAMINATION
More informationChromatographic Workflows for Biopharmaceutical Characterization
Chromatographic Workflows for Biopharmaceutical Characterization Dr. Ken Cook European Bioseparation Sales Support Expert Thermo Fisher Scientific, Hemel Hempstead/Germany The world leader in serving science
More informationAgilent Biocolumns. Glycan Analysis. Application Compendium
Agilent Biocolumns Glycan Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Glycan Mapping 4 Featured Application Notes 12 Fast and Efficient HILIC Methods for Improved
More informationMass Spectrometry Analysis of Liquid Chromatography Fractions using Ettan LC MS System
GUIDE TO LC MS - December 21 1 Spectrometry Analysis of Liquid Chromatography Fractions using Ettan LC MS System Henrik Wadensten, Inger Salomonsson, Staffan Lindqvist, Staffan Renlund, Amersham Biosciences,
More informationGenerating Automated and Efficient LC/MS Peptide Mapping Results with the Biopharmaceutical Platform Solution with UNIFI
with the Biopharmaceutical Platform Solution with UNIFI Vera B. Ivleva, Ying Qing Yu, Scott Berger, and Weibin Chen Waters Corporation, Milford, MA, USA A P P L I C AT ION B E N E F I T S The ability to
More informationIntact Glycoprotein Isoforms Separation on Proteomix Strong Anion Exchange (SAX) Chromatography Using Salt and ph Gradients
Authors Haiying Chen Katherine McLaughlin Sepax Technologies, Inc. Innovation Way Newark, DE 19711 USA Intact Glycoprotein Isoforms Separation on Proteomix Strong Anion Exchange (SAX) Chromatography Using
More informationAssessing Glycosimilarity of Biotherapeutics
Assessing Glycosimilarity of Biotherapeutics Andras Guttman, 1 Beata Borza, 2 Marton zigeti, 2 Akos zekrenyes, 2 Laszlo Hajba 2 1 CIEX eparations, Brea, CA; 2 Horváth Csaba Laboratory of Bioseparation
More informationThank you for joining us! Our Webinar will begin shortly Principles of SPE: Troubleshooting Techniques
Thank you for joining us! Our Webinar will begin shortly Principles of SPE: Troubleshooting Techniques Using the Power of Chromatography to Solve Sample Preparation Challenges 2013 Waters Corporation 1
More informationNISTmAb characterization with a high-performance RP chromatography column
APPLICATION NOTE 21848 NISTmAb characterization with a high-performance RP chromatography column Author Xin Zhang Thermo Fisher Scientific, Sunnyvale, CA, USA Keywords MAbPac RP column, inter-column reproducibility,
More informationSimultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements
Simultaneous Quantitation of a Monoclonal Antibody and Two Proteins in Human Plasma by High Resolution and Accurate Mass Measurements Paul-Gerhard Lassahn 1, Kai Scheffler 2, Myriam Demant 3, Nathanael
More informationProPac Elite WCX, 5 μm Particle, for Fast, High Resolution Protein and mab Analysis. July 2018
ProPac Elite WCX, 5 μm Particle, for Fast, High Resolution Protein and mab Analysis July 218 ProPac Elite WCX Acidic Variants Basic Variants 5µm Weak Cation Exchange Column Chemistry based on Thermo Scientific
More informationCharacterization of a fusion protein under native and denaturing conditions with maxis II
Characterization of a fusion protein under native and denaturing conditions with maxis II Abstract The maxis II UHR-QTOF was used to characterize key attributes of a fusion protein in its native conformation
More informationAdvantages of Ion Mobility QTOF for Characterization of BioPharma Molecules
Advantages of Ion Mobility QTOF for Characterization of BioPharma Molecules Add a New Dimension to your Research Capability with Agilent s New Drift Ion Mobility QTOF System David Wong, Ph.D. Sr. Application
More informationA comprehensive CE/ESI-MS solution for BioPharma applications
A comprehensive CE/ESI-MS solution for BioPharma applications Thermo Scientific Q Exactive hybrid quadrupole-orbitrap mass spectrometers with ZipChip system Fast CE Separation Nanospray Sensitivity HRAM
More informationPut the PRO in Protein Characterization
Put the PRO in Protein Characterization Aaron Boice LC/Q-TOF Product Manager 5-June-2017 Agenda The Right Tools for the Job Tackling Intact Proteins Break it Down Peptides and PTMs Sweet Success Released
More informationDisulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column
Disulfide Linkage Analysis of IgG1 using an Agilent 126 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Application Note Biotherapeutics & Biosimilars Author M. Sundaram
More informationSeparate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC
Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC The Agilent 126 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 3Å, 2.7 µm Column Application Note Biologics
More informationA Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies
A Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies Combining Size Exclusion Chromatography with Method Development and Light Scattering Application Note Biotherapeutics and Biosimilars
More informationColumns for Biomolecules BioLC Column Lines
Columns for Biomolecules BioLC Column Lines Monoclonal Antibodies Glycans GlycanPac Nucleic Acids DNAPac Protein A Accucore Amide-HILIC DNAPac PA1 SEC-1 GlycanPac AXH-1 DNAPac PA2 SCX-1 GlycanPac AXR-1
More informationApplication Note. Authors. Abstract. Biopharmaceuticals
Characterization of monoclonal antibodies on the Agilent 126 Infinity Bio-inert Quaternary LC by Size Exclusion Chromatography using the Agilent BioSEC columns Application Note Biopharmaceuticals Authors
More informationFast Glycan Sequencing Using a Fully Automated Carbohydrate Sequencer
Fast Glycan Sequencing Using a Fully Automated Carbohydrate Sequencer Andras Guttman 1 and Marton Szigeti 2 1 SCIEX Separations, Brea, CA 2 Horváth Csaba Laboratory of Bioseparation Sciences, Debrecen,
More informationHigh-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks
High-Throughput Glycan Screening to Remove Biopharmaceutical Development Bottlenecks Mark Lies, Marcia Santos, and Tingting Li SCIEX Separations, Brea, CA Introduction Development of biopharmaceuticals
More informationIgG Purity/Heterogeneity and SDS-MW Assays with High- Speed Separation Method and High Throughput Tray Setup
IgG Purity/Heterogeneity and SDS-MW Assays with High- Speed Separation Method and High Throughput Tray Setup High Throughput Methods to Maximize the Use of the PA 800 Plus system Jose-Luis Gallegos-Perez
More informationImpurity Detection with a New Light Emitting Diode Induced Fluorescence Detector Coupled to the Agilent 7100 Capillary Electrophoresis System
Impurity Detection with a New Light Emitting Diode Induced Fluorescence Detector Coupled to the Agilent 7100 Capillary Electrophoresis System Application Note Biologics & Biosimilars, Proteomics & Protein
More informationQuantitative Analysis of pesticides including Phenoxy-acids in surface and drinking water matrices using UPLC-ON-LINE-SPE-MS/MS
Quantitative Analysis of pesticides including Phenoxy-acids in surface and drinking water matrices using UPLC-ON-LINE-SPE-MS/MS Alexandre Paccou Demo Centers and Application Support Manager, Southern Europe
More informationApplication of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study
Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study Application note Biotherapeutics and Biologics Authors Suresh Babu C.V., Anne
More informationBiotherapeutic Method Development Guide
Biotherapeutic Method Development Guide HALO BIOCLASS 1000 Å PROTEIN SELECTIVITY KIT Fused-Core Particle Technology BIOCLASS Strategy for Optimizing Protein Separations Using Reversed-phase Liquid Chromatography
More informationAgilent AssayMAP Bravo Platform AUTOMATED PROTEIN AND PEPTIDE SAMPLE PREPARATION FOR MASS SPEC ANALYSIS
Agilent AssayMAP Bravo Platform AUTOMATED PROTEIN AND PEPTIDE SAMPLE PREPARATION FOR MASS SPEC ANALYSIS GET FAST, ACCURATE, REPRODUCIBLE RESULTS The Agilent AssayMAP platform is an easy to use yet flexible
More informationFaster, easier, flexible proteomics solutions
Agilent HPLC-Chip LC/MS Faster, easier, flexible proteomics solutions Our measure is your success. products applications soft ware services Phospho- Anaysis Intact Glycan & Glycoprotein Agilent s HPLC-Chip
More informationLabChip GXII: Antibody Analysis
WHITE PAPER LabChip GXII: Antibody Analysis Antibody Analysis using microfluidic technology in high throughput Quality by Design Experiments Abstract Current initiatives in Process Analytical Technology
More informationAgilent AssayMAP Platform BIOLOGICS SAMPLE PREPARATION INTELLIGENTLY AUTOMATED
Agilent AssayMAP Platform BIOLOGICS SAMPLE PREPARATION INTELLIGENTLY AUTOMATED SIMPLIFY BIOLOGICS SAMPLE PREPARATION The Agilent AssayMAP platform is an open access, walkaway automation solution specifi
More informationMicroflow LC-MS with the turn of a key
[ ionkey/ms ] Microflow LC-MS with the turn of a key Dramatically enhance your sensitivity for both quantitative and qualitative chromatographic data, with an integrated microflow LC-MS solution that is
More informationACQUITY Arc TM System
ACQUITY Arc TM System Introducing the Newest Member of the Waters LC Portfolio 2015 Waters Corporation 1 Adopting Modern LC Technology in a Global Economy Highly competitive, regulated business environment
More informationStrategies for Quantitative Proteomics. Atelier "Protéomique Quantitative" La Grande Motte, France - June 26, 2007
Strategies for Quantitative Proteomics Atelier "Protéomique Quantitative", France - June 26, 2007 Bruno Domon, Ph.D. Institut of Molecular Systems Biology ETH Zurich Zürich, Switzerland OUTLINE Introduction
More informationMicrochip Electrophoresis for Glycoprotein Separation. Analytical Strategy, September 30th, 2014 Karina Hasler & Adrian Müller
Microchip Electrophoresis for Glycoprotein Separation Analytical Strategy, September 30th, 2014 Karina Hasler & Adrian Müller Karina Hasler & Adrian Müller 30.09.2014 1 Content Glycoproteins Available
More informationStreamlined and Complete LC-MS Workflow for MAM
Streamlined and Complete LC-MS Workflow for MAM Multiple Attribute Methodology (MAM) for Biotherapeutic Attribute Monitoring and Purity Testing BV MAM WORKFLOW Define Track Quantify Purity New Peaks Report
More informationBiotherapeutic Method Development Guide
Biotherapeutic Method Development Guide HALO BIOCLASS 1000 Å PROTEIN SELECTIVITY KIT Fused-Core Particle Technology BIOCLASS Strategy for Optimizing Protein Separations Using Reversed-phase Liquid Chromatography
More informationApplication Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass
Application Note LCMS-87 Automated Acquisition and Analysis of Data for Monitoring Protein Conjugation by LC-MS Using BioPharma Compass Abstract Here we describe the development and use of an automated
More informationLavaDigest Protease Monitoring Kit
LavaDigest Protease Monitoring Kit Ordering LP-031020 LavaDigest protease monitoring kit for up to 2000 assays Order from http://www.fluorotechnics.com.au L.avaDigest Protocol March 2013 Content 2 LavaDigest
More informationSupplementary Figure S1 Supplementary Figure S2 Supplementary Figure S3. Supplementary Figure S4
Supplementary Figure S1 Supplementary Figure S2 Supplementary Figure S3 Supplementary Figure S4 Supplementary Figure S5 Supplementary Figure S6 Supplementary Figure S7 Supplementary Figure S8 Supplementary
More informationrapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF
rapiflex Designed for Molecules that Matter. Innovation with Integrity MALDI TOF/TOF rapiflex TM The first MALDI-TOF/TOF that adapts to your needs. The rapiflex is the most advanced MALDI TOF/TOF system
More informationZipChip TM. Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications. Please visit us at
ZipChip TM Microfluidic CE-ESI Biotherapeutics CE-ESI-MS Applications Please visit us at http://www.908devices.com/ // Actionable Intelligence HPMS & On-board Analytics / Slide 1 June 2016 // ZipChip CE-ESI
More informationDemonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance
Demonstrating Biosimilarity of a Therapeutic Protein Product to a Reference Product ICH Guidance Derek Bradley M.Sc. BioClin Research Laboratories 13 th May 2016 Agenda Brief overview of biosimilars ICH
More informationHongwei Xie, Martin Gilar, and John C. Gebler Waters Corporation, Milford, MA, U.S.A. INTRODUCTION EXPERIMENTAL
Analysis of Deamidation and Oxidation in MONOCLONAL Antibody Using Peptide Mapping with UPLC/MS E Hongwei Xie, Martin Gilar, and John C. Gebler Waters Corporation, Milford, MA, U.S.A. INTRODUCTION Monoclonal
More informationA highly sensitive and robust 150 µm column to enable high-throughput proteomics
APPLICATION NOTE 21744 Robust LC Separation Optimized MS Acquisition Comprehensive Data Informatics A highly sensitive and robust 15 µm column to enable high-throughput proteomics Authors Xin Zhang, 1
More informationEnhance Your Protein Interaction Research with A New Level of Bench-Top Productivity
LAMDAGEN C O R P O R A T I O N Enhance your research with real-time monitoring and quantitation of biomolecular binding with highly sensitive detection in a label-free format 9 Enhance Your Protein Interaction
More informationMass Detection for the Chromatographer Waters ACQUITY QDa Detector
Mass Detection for the Chromatographer Waters ACQUITY QDa Detector Warren B Potts III Senior Director Americas Marketing warren_potts@waters.com 2017 Waters Corporation 1 Agenda Overview of technology
More informationFast and High Resolution Analysis of Intact and Reduced Therapeutic Monoclonal Antibodies (mabs)
Fast and High Resolution nalysis of Intact and Reduced Therapeutic Monoclonal ntibodies (mbs) The gilent io-inert L and dvanceio RP-mb olumns pplication Note io-pharmaceutical uthor M. Sundaram Palaniswamy
More informationUse of alternative chromatographic phases and LC-MS for characterization of N-glycans from NISTmAb RM 8671
APPLICATION NOTE 21738 Use of alternative chromatographic phases and LC-MS for characterization of N-glycans from NISTmAb RM 8671 Authors Amy Farrell, Silvia Millan Martin, Csaba Váradi, and Jonathan Bones,
More informationAgilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis. WCBP Jan 2017 Washington, DC
Agilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis WCBP Jan 2017 Washington, DC 1 Overview Resolving power and how to measure it Why two-dimensional LC? Setup of a 2D-LC System
More informationHigh Throughput Sub-4 Minute Separation of Antibodies using Size Exclusion Chromatography
High Throughput Sub-4 Minute Separation of Antibodies using Size Exclusion Chromatography TSKgel APPLICATION NOTE Introduction Gel Filtration Chromatography (GFC) is a powerful analytical tool in the separation
More informationCharacterization of Glycosylation in the Fc Region of Therapeutic Recombinant Monoclonal Antibody
Characterization of Glycosylation in the Fc Region of Therapeutic Recombinant Monoclonal Antibody Application Note BioPharma Authors James Martosella, Phu Duong, and Alex Zhu Agilent Technologies, Inc.
More information